Do you ever have moments when you stand in front of the mirror longer than you should and don’t recognize the person staring back at you? Sometimes I look at myself, and my tired eyes, stress wrinkles, and bloated face make my appearance unfamiliar. It’s a body that resembles…
NMOSD
A blood test measuring levels of the GPR37 protein may help diagnose neuromyelitis optica spectrum disorder (NMOSD), assess disease severity, and monitor treatment response, according to a new study. The GPR37 test was also able to distinguish NMOSD from multiple sclerosis (MS) and other neurological disorders. “Our findings…
Nearly all adults with neuromyelitis optica spectrum disorder (NMOSD) experience headaches, especially migraines, a single-center study in Iran suggests. The presence of abnormalities in brain MRI scans and the use of the immunosuppressive therapy rituximab were each linked to an increased chance of new or worsening headaches after a…
People with neuromyelitis optica spectrum disorder (NMOSD) have significantly higher levels of the signaling molecule CXCL13 in their blood and cerebrospinal fluid (CSF), the liquid surrounding the brain and spinal cord, a study shows. Also, CXCL13 levels were significantly associated with disability, with higher levels being detected in NMOSD…
Cedars-Sinai was designated a Center of Excellence in Rare Neuroimmune Disorders due to its efforts at advancing care and research for rare immune-mediated diseases of the central nervous system (brain, spinal cord and optic nerve), such as neuromyelitis optica spectrum disorder (NMOSD). The designation was awarded by the patient advocacy…
People who are Asian or Pacific Islander and Black are more likely to have neuromyelitis optica spectrum disorder (NMOSD) and test positive for self-reactive antibodies against aquaporin-4 (AQP4) than white people, a U.S.-based study suggests. The prevalence of anti-AQP4 antibody-positive NMOSD was also higher among women and Hispanic people.
BAT4406F, an experimental treatment in the pipeline of Bio-Thera Solutions, reduced the number of circulating immune B-cells that produce disease-causing antibodies in neuromyelitis optica spectrum disorder (NMOSD), translating into less disability for a small group of Chinese patients. That’s according to data from a Phase 1 clinical…
Self-reactive antibodies linked to other autoimmune diseases are more common in people with neuromyelitis optica spectrum disorder (NMOSD) than in those with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), a related condition. In fact, the frequency of any other autoimmune disease was nearly six times higher in adults with NMOSD…
Shingles is caused by an infection of the varicella-zoster virus (VZV), but in rare cases, it may trigger neuromyelitis optica spectrum disorder (NMOSD), a new study reports. The study’s researchers said clinicians should look for possible signs of NMOSD in patients being treated for shingles, even though developing NMOSD…
People with neuromyelitis optica spectrum disorder (NMOSD) who test positive for NMOSD-driving self-reactive antibodies against the AQP4 protein and Black patients are significantly more likely to have worse disability related to vision. These are the findings of a North American study that analyzed patient data with NMOSD-specific disability scales…
Recent Posts
- Conventional NMOSD treatment effective in double-negative cases
- Grieving how NMOSD has left me uncomfortable in my own skin
- Enspryng outperforms standard immunosuppressants in NMOSD study
- Slow and steady: I’m ditching big resolutions and easing into a new year
- Late-onset NMOSD responds better to newer, highly effective therapies
- New biomarker may help gauge disease severity in NMOSD
- The longest night of the year offers hope of brighter days with NMOSD
- Advanced plasma exchange therapy effectively eases NMOSD attacks
- Reaffirming that access to healthcare is a human right
- Brain, spinal cord shrinkage linked to distinct NMOSD outcomes: Study